<document id="bone_marrow">
	<sentence>About 85 % of the cell population in this <cell_type>bone</cell_type> tissueare osteocytes and the remainder are osteoblasts , bone <cell_type>marrow</cell_type> ,etc . </sentence>
	<sentence>A detailed characterization of the mRNA- and <cell_type>microRNA</cell_type> transcriptomesduring adipocyte differentiation also <cell_type>showed</cell_type> thatthe iMSC # 3 recapitulates this process at the molecular level . </sentence>
	<sentence>After informed consent , <cell_type>bone marrow</cell_type> specimenspacked with leukemic blasts were obtained in each patient . </sentence>
	<sentence>APL patients showed increased genome-wide DNA methylation with higher variability than healthy CD34+ cells , promyelocytes and remission <cell_type>bone marrow</cell_type> .</sentence>
	<sentence>Bisulphite <cell_type>converted</cell_type> DNAfrom all samples were hybridised to the Illumina Infinium 450 Human Methylation <cell_type>arrays</cell_type> andfor each analysis the drug treated sample was compared to the corresponding PBS control sample . </sentence>
	<sentence><cell_type>Bone marrow-derived</cell_type> mesenchymalstroma cells ( MSCs ) have many of the properties of multipotent stem cells , and can be differentiated towards osteoblasts in vitro , making these cells a convenient tool for investigation of osteogenesis . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 00_751 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 01_1808 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 02_1505 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 02_1522 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 02_1550 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 02_723 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 03_106 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 03_1310 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 03_1380 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 04_126 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 04_6 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 05_1464 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 05_170 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 05_579 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 06_2096 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 06_518 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 06_758 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 07_1768 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 07_1962 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 07_2252 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 08_151 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 08_723 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 08_774 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 08_785 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 08_930 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 10_1420 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 10_1789 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 11_834 . </sentence>
	<sentence><cell_type>Bone marrow</cell_type> mononuclearcells , 12_254 . </sentence>
	<sentence><cell_type>bone marrow</cell_type> mononuclearcells , leukemia . </sentence>
	<sentence>cell description : neuroblastoma , BE-C is a clone of the SK-N-BE neuroblastoma cell line ( see ATCC CRL-2271 ) that was established in November of 1972 from a <cell_type>bone marrow</cell_type> biopsytaken from a 2-year-old individual with disseminated neuroblastoma after repeated courses of chemotherapy and radiotherapy . </sentence>
	<sentence>Cells able to form <cell_type>bone</cell_type> throughendochondral ossification and attract bone <cell_type>marrow</cell_type> inan innovative in vivo model were compared to cells lacking these capacities . </sentence>
	<sentence>cell type : <cell_type>bone marrow</cell_type> mononuclearcells . </sentence>
	<sentence>CMP of normal <cell_type>bone marrow</cell_type> .</sentence>
	<sentence>CN-AML blasts isolated from patient <cell_type>bone marrow</cell_type> aspriationwere compared to CD34+ cell population from healthy donors by DNA methylation array and affymetrix gene expression microarray . </sentence>
	<sentence>Comparing four commonly use MSC sources ( <cell_type>bone marrow</cell_type> (BM ) , white adipose tissue ( WAT ) , umbilical cord ( UC ) and skin ) we found only bone marrow ( BM ) -derived MSCs capable of endochondral ossification and marrow attraction . </sentence>
	<sentence>Despite similarities in morphology , phenotype and in vitro behavior , Mesenchymal Stromal Cells ( MSC ) form <cell_type>various</cell_type> tissuesources show striking differences in their in vivo potential to form <cell_type>bone</cell_type> ,cartilage and hematopoietic support tissue . </sentence>
	<sentence>Despite similarities in morphology , phenotype and in vitro behavior , Mesenchymal Stromal Cells ( MSC ) form <cell_type>various</cell_type> tissuesources show striking differences in their in vivo potential to form <cell_type>bone</cell_type> ,cartilage and hematopoietic support tissue . </sentence>
	<sentence>DNA methylation ( DNAm ) profiles of iPSCs <cell_type>maintained some</cell_type> donor-specificcharacteristics , whereas tissue-specific , senescence-associated , and age-related DNAm patterns were erased during reprogramming . </sentence>
	<sentence>During embryogenesis , body <cell_type>growth</cell_type> andrepair the <cell_type>bone</cell_type> substanceis formed by osteoblasts , which are derived from mesenchymal stem cells . </sentence>
	<sentence>Established iPSCs were maintained <cell_type>on</cell_type> MEFsin DMEM/F12 medium supplemented with Glutamax , 20 % knockout serum replacer , 1 % nonessential amino acids , 1x penicillin/streptomycin , 1x L-glutamine , 0.1 mM Î²-Mercaptoethanol , and 50 ng/ml basic fibroblast <cell_type>growth</cell_type> factor( Peprotech , Hamburg , Germany ) . </sentence>
	<sentence>Expression and methylation data <cell_type>of</cell_type> purifiedPre-B cells in four developmental stages were retrieved <cell_type>from</cell_type> ourprevious study ( Lee et al. , Nucleic Acids Res 2012 ) . </sentence>
	<sentence>For 8 indibiduals , DNAs and RNAs were isolated and the methylation and expression changes during early B-cell development were identified using the Illumina HumanMethylation450 Beadchip ( Illumina ) and GeneChip Human <cell_type>Gene</cell_type> 1.0ST <cell_type>Array</cell_type> (Affymetrix ) . </sentence>
	<sentence>Furthermore , hypermethylation in iP-MSC versus ESC was particularly enriched in developmental <cell_type>genes</cell_type> aswell as shore regions next to CpG islands indicating that these differences <cell_type>are</cell_type> notdue to tissue-specific memory or random de novo methylation . </sentence>
	<sentence>Furthermore , iMSC # 3 <cell_type>showed</cell_type> nomajor differences from hMSCs regarding surface <cell_type>marker</cell_type> expression. </sentence>
	<sentence>genomic DNA from <cell_type>bone marrow</cell_type> CD34+cells 5729917060_RO3CO2 . </sentence>
	<sentence>genomic DNA from <cell_type>bone marrow</cell_type> CD34+cells 5729917060_RO4CO2 . </sentence>
	<sentence>genomic DNA from <cell_type>bone marrow</cell_type> CD34+cells 5729917060_RO5CO2 . </sentence>
	<sentence>genomic DNA from <cell_type>bone marrow</cell_type> CD34+cells 5729917060_RO6CO2 . </sentence>
	<sentence>genomic DNA from <cell_type>bone marrow</cell_type> CD34+cells 8359018137_RO1CO1 . </sentence>
	<sentence>genomic DNA from <cell_type>bone marrow</cell_type> CD34+cells 8359018152_RO1CO1 . </sentence>
	<sentence>genomic DNA from <cell_type>bone marrow</cell_type> CD34+cells 8363800011_RO1CO1 . </sentence>
	<sentence>genomic DNA from <cell_type>bone marrow</cell_type> CD34+cells 8363800011_RO2CO1 . </sentence>
	<sentence>genomic DNA from <cell_type>bone marrow</cell_type> CD34+cells 8363800026_RO1CO1 . </sentence>
	<sentence>genomic DNA from <cell_type>bone marrow</cell_type> CD34+cells 8363800026_RO2CO1 . </sentence>
	<sentence>GMP of normal <cell_type>bone marrow</cell_type> .</sentence>
	<sentence>However , <cell_type>a</cell_type> disadvantageof primary hMSCs is the limited in vitro lifespan , but this can <cell_type>be</cell_type> overcomeby introduction of the catalytic subunit of human telomerase reverse transcriptase ( TERT ) . </sentence>
	<sentence>HSC of normal <cell_type>bone marrow</cell_type> .</sentence>
	<sentence>Human DNA methylation Beadchip v1.2 was used <cell_type>to</cell_type> obtainDNA methylation profiles <cell_type>across</cell_type> approximately486,000 CpGs . </sentence>
	<sentence>Human fetal <cell_type>bone marrow</cell_type> wasobtained , and using flow cytometry antibodies , four populations of B-cell developmental stages including stage 1 ( S1 ; predominantly multipotent progenitors before lineage commitment and common lymphoid progenitors ) , stage II ( S2 ; pre-B-I cells ) , stage 3 ( S3 ; pre-B-II cells ) and stage 4 cells ( S4 ; immature B cells ) . </sentence>
	<sentence>Immortalized human <cell_type>bone marrow-derived</cell_type> mesenchymalstromal cell line DNA methylation [ iMSC # 3 ( Culture I ) ] . </sentence>
	<sentence>Immortalized human <cell_type>bone marrow-derived</cell_type> mesenchymalstromal cell line DNA methylation [ iMSC # 3 ( Culture II ) ] . </sentence>
	<sentence>iMSC # 3 were <cell_type>grown under</cell_type> thesame condition as hMSCs , but the medium was supplemented with 10 % FBS . </sentence>
	<sentence>In conclusion , a human <cell_type>bone marrow-derived</cell_type> stromalcell line was developed , which can be used for basic studies of mesenchymal cells and to functionally study transgenes that might play a role in oncogenic transformation . </sentence>
	<sentence>In conclusion , DNA methylation profiles of iP-MSC <cell_type>clones from</cell_type> thesame donor were closely related despite heterogeneity of MSC . </sentence>
	<sentence>In contrast , induced pluripotent stem cells ( iPSCs ) assimilate towards a ground-state and <cell_type>may</cell_type> thereforegive rise to <cell_type>more</cell_type> standardizedcell preparations . </sentence>
	<sentence>In the absence of isogenic controls for disease modeling applications , it would therefore be more appropriate to compare iPSC from different donors rather than <cell_type>a</cell_type> highnumber of different <cell_type>clones</cell_type> fromthe same patient . </sentence>
	<sentence>In the absence of isogenic controls for disease modeling applications , it would therefore be more appropriate to compare iPSC from different donors rather than <cell_type>a</cell_type> highnumber of different <cell_type>clones</cell_type> fromthe same patient . </sentence>
	<sentence>In this paper , the generation and characterization of a TERT-immortalized , non-tumorigenic human <cell_type>bone marrow-derived</cell_type> stromalmesenchymal model cell line is described . </sentence>
	<sentence>In this study , we have analyzed DNA methylation characteristics of human mesenchymal stem and progenitor cells ( MSPCs ) form different tissue sources including <cell_type>bone marrow</cell_type> (BM ) , white adipose tissue ( WAT ) , umbilical cord ( UC ) as well as dermal fibroblasts by using the HumanMethylation450K array . </sentence>
	<sentence>In this study we have reprogrammed mesenchymal stromal cells ( MSC ) from human <cell_type>bone marrow</cell_type> byretrovirus-mediated overexpression of OCT-3/4 , SOX2 , c-MYC , and KLF4 . </sentence>
	<sentence>It has <cell_type>been</cell_type> suggestedthat iPSC retain some tissue-specific memory whereas little is known about inter-individual epigenetic <cell_type>variation</cell_type> ofiPSC clones . </sentence>
	<sentence>L-MPP of normal <cell_type>bone marrow</cell_type> .</sentence>
	<sentence>Lymphoprep extraction of leukocytes was performed following 30 <cell_type>min</cell_type> no<cell_type>brake</cell_type> centrifugation. </sentence>
	<sentence>MEP of normal <cell_type>bone marrow</cell_type> .</sentence>
	<sentence>Mononuclear cells from the <cell_type>bone marrow</cell_type> wereisolated using standard density centrifugation and cultured in minimum essential medium ( MEM ) Alpha medium ( cat . </sentence>
	<sentence>MPP of normal <cell_type>bone marrow</cell_type> .</sentence>
	<sentence>MSCs from three donors were infected with pMXs <cell_type>based</cell_type> retroviruses( Addgene , Cambridge , MA , USA ) <cell_type>carrying</cell_type> theOCT3/4 , SOX2 , KLF4 , and c-MYC genes . </sentence>
	<sentence>MSCs were isolated from <cell_type>bone marrow</cell_type> (tibia plateau ) after written consent using guidelines approved by the Ethic Committee of the Use of Human Subjects at the University of Aachen ( permit number : EK128/09 ) . </sentence>
	<sentence>MSCs were subcutaneously implanted into immune-compromised mice to comparatively evaluate <cell_type>bone</cell_type> formationand subsequent bone <cell_type>marrow</cell_type> attraction. </sentence>
	<sentence><cell_type>Non-adherent</cell_type> cellswere removed <cell_type>after</cell_type> approximately24 h by replacement of the medium . </sentence>
	<sentence>Patient and donor samples were obtained either from blood or <cell_type>bone marrow</cell_type> .</sentence>
	<sentence>primary cells isolated from patient 's blood or <cell_type>bone marrow</cell_type> .</sentence>
	<sentence>Primary hMSCs were <cell_type>obtained</cell_type> fromthe hip of <cell_type>a</cell_type> healthydonor after informed consent . </sentence>
	<sentence>Reprogramming of somatic cells into <cell_type>induced</cell_type> pluripotentstem cells ( iPSC ) is <cell_type>an</cell_type> epigeneticphenomenon . </sentence>
	<sentence>Reprogramming of somatic cells into <cell_type>induced</cell_type> pluripotentstem cells ( iPSC ) is <cell_type>an</cell_type> epigeneticphenomenon . </sentence>
	<sentence>RUNX2 target <cell_type>genes</cell_type> wereassociated with cellular <cell_type>growth</cell_type> ,movement , apoptosis and PDGF BB and p53 signaling . </sentence>
	<sentence>sample origin : Human <cell_type>bone marrow-derived</cell_type> mesenchymalstromal cell . </sentence>
	<sentence>Samples included 20 leukemia stem cells , 24 blast cells and 30 normal hematopoietic stem and progenitor cells ( 6 different types from 5 normal <cell_type>bone marrows</cell_type> ). </sentence>
	<sentence>Self-renewal and multipotent differentiation capacity <cell_type>are</cell_type> keyelements <cell_type>in</cell_type> theincreasing interest of this cell type . </sentence>
	<sentence>Sorted normal <cell_type>bone marrow</cell_type> cellsfrom healthy volunteers at Washington University . </sentence>
	<sentence>Standardization <cell_type>of</cell_type> mesenchymalstromal cells ( MSCs ) remains a <cell_type>major</cell_type> obstaclein regenerative medicine . </sentence>
	<sentence>Starting <cell_type>material</cell_type> andculture expansion affect cell preparations and render comparison <cell_type>between</cell_type> studiesdifficult . </sentence>
	<sentence>Subsequently , we searched for CpG sites with <cell_type>donor-specific variation</cell_type> inMSC preparations . </sentence>
	<sentence>Surprisingly , RUNX2 was found to bind both at the 5 â and 3 â ends of genes , and <cell_type>also</cell_type> atdistal regulatory elements , and was co-localized with activating histone modifications at approximately half of <cell_type>bound</cell_type> sites. </sentence>
	<sentence>The <cell_type>gene</cell_type> expressionprofiles of immortalized and primary hMSCs were also similar , whereas the corresponding methylation profiles were <cell_type>more</cell_type> diverse. </sentence>
	<sentence>The Illumina Infinium 450k Human DNA methylation Beadchip was used <cell_type>to</cell_type> obtainDNA methylation profiles <cell_type>across</cell_type> approximately450,000 CpGs in the samples . </sentence>
	<sentence>The origin of <cell_type>aberrant</cell_type> DNAmethylation in <cell_type>cancer</cell_type> remainslargely unknown . </sentence>
	<sentence>The resulting cell line , iMSC # 3 , maintained capacity to differentiate into osteoblasts and adipocytes , and <cell_type>growth</cell_type> characteristicscomparable to primary hMSCs into after <cell_type>long-term</cell_type> culturing( 155 population doublings ) . </sentence>
	<sentence>These â epigenetic fingerprints â were highly enriched in non-promoter regions and outside of CpG islands â and they were <cell_type>maintained upon</cell_type> reprogramminginto iP-MSC . </sentence>
	<sentence>These features correlated with <cell_type>unique</cell_type> epigenetic<cell_type>characteristics</cell_type> potentiallyenabling BM-derived cells to undergo endochondral ossification . </sentence>
	<sentence>These iPS-MSCs revealed similar morphology , immunophenotype , in <cell_type>vitro</cell_type> differentiationpotential , and <cell_type>gene</cell_type> expressionprofiles as primary MSCs . </sentence>
	<sentence>These results suggest that <cell_type>aberrant</cell_type> DNAmethylation is associated with leukemia phenotype but not required for PML-RARa-mediated initiation of leukemogenesis . </sentence>
	<sentence>The study investigated the changes in DNA-methylation and <cell_type>gene expression</cell_type> duringgranulopoiesis . </sentence>
	<sentence>The trabecular <cell_type>bone</cell_type> pieceswere obtained <cell_type>from</cell_type> thecentral part of the femoral head of Spanish ( Caucasian ) patients with hip fractures ( due to osteoporosis ) or subjects with osteoarthritis . </sentence>
	<sentence>This is to our knowledge the first genome-wide description of RUNX2 <cell_type>targets</cell_type> in<cell_type>bone</cell_type> biology. </sentence>
	<sentence>To exclude contamination of feeder layer cells , iPSCs were adjusted to <cell_type>a</cell_type> feeder-freesystem <cell_type>on</cell_type> matrigel( BD Biosciences , San Jose , CA , USA ) in mTeSRâ¢1 medium ( Stemcell Technologies , Vancouver , BC , Canada ) for at least three passages . </sentence>
	<sentence>To gain mechanistic insights explaining this differences we analyzed <cell_type>gene</cell_type> expressioncharacteristics of MSC <cell_type>from</cell_type> allfour tissue sources using Affymetrix Genechip Human Gene 2.0 ST Array . </sentence>
	<sentence>To gain mechanistic insights explaining this differences we analyzed <cell_type>gene</cell_type> expressioncharacteristics of MSC <cell_type>from</cell_type> allfour tissue sources using Affymetrix Genechip Human Gene 2.0 ST Array . </sentence>
	<sentence>Unexpectedly , PML-RARa <cell_type>binding</cell_type> siteswere also protected from <cell_type>aberrant</cell_type> DNAmethylation in APL . </sentence>
	<sentence>We here describe the pattern of gene expression , histone modification and DNA binding of the <cell_type>bone</cell_type> masterregulator RUNX2 during osteogenic differentiation of an immortalized human bone <cell_type>marrow-derived</cell_type> MSCcell line . </sentence>
	<sentence>Where available , purification was performed using MACS columns <cell_type>following</cell_type> anti-CD34bead conjugation <cell_type>to</cell_type> samples( anti-CD14 for CD14 samles ) . </sentence>
</document>